Xolair 75 mg solution for injection in pre-filled syringe
APHP180614
Approved small_molecule active
Quick answer
Xolair 75 mg solution for injection in pre-filled syringe for Well controlled severe allergic asthma is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Well controlled severe allergic asthma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active